Stocks
GlaxoSmithKline (GSK) OCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| OCF, £ | ? | 7 952 000 000 | 8 160 543 693 | 7 890 893 093 | 6 554 000 000 | 7 142 957 939 | 8 300 913 532 | ||
| Changes by years, y/y, % | -6% | +3% | -3% | -17% | +9% | -3.3% | |||
GlaxoSmithKline. OCF, £
GlaxoSmithKline. OCF, changes, %
GlaxoSmithKline. OCF, sum by quarters, £
GlaxoSmithKline (GSK) OCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| OCF, £ | ? | 1 145 000 000 | 2 096 000 000 | 3 027 580 859 | 2 036 332 673 | 1 141 000 000 | 8 300 913 532 | |
| Changes by years, y/y, % | -4% | +88% | +41% | -13% | 0% | |||
| Changes by quarters, q/q, % | -51% | +83% | +44% | -33% | -44% | |||
